Net profit of Pfizer rose 37.96% to Rs 178.86 crore in the quarter ended March 2024 as against Rs 129.65 crore during the previous quarter ended March 2023. Sales declined 4.54% to Rs 546.63 crore in the quarter ended March 2024 as against Rs 572.64 crore during the previous quarter ended March 2023.
For the full year,net profit declined 11.64% to Rs 551.33 crore in the year ended March 2024 as against Rs 623.93 crore during the previous year ended March 2023. Sales declined 9.55% to Rs 2193.17 crore in the year ended March 2024 as against Rs 2424.76 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 546.63 | 572.64 | -5 | 2193.17 | 2424.76 | -10 |
| OPM % | 34.65 | 31.76 | - | 28.97 | 33.36 | - |
| PBDT | 257.61 | 210.72 | 22 | 800.40 | 896.52 | -11 |
| PBT | 243.86 | 184.31 | 32 | 738.12 | 791.01 | -7 |
| NP | 178.86 | 129.65 | 38 | 551.33 | 623.93 | -12 |